This autumn, the Community of Madrid will incorporate child immunization against the respiratory syncytial virus (RSV), which causes bronchiolitis in children. babies between zero and six months. It will be from October. The bronchiolitis that leads babies to hospital admission is usually caused by a complication of the Respiratory Syncytial Virus and seriously affects 1 in 56 healthy, non-preterm babies.
The General Directorate of Public Health is already working on planning this new primary prevention program for the acquisition of the most effective immunization among those that are about to be marketed.
Respiratory syncytial virus (VRS)
Respiratory Syncytial Virus is a common and contagious seasonal pathogen that infects the lower respiratory tract, most commonly affecting infants. Generally, the detection of cases of infection by this virus increases from October, reaching its epidemic peak between December and January.
Bronchiolitis could spread to spring and summer, according to experts
This virus is the cause of most bronchiolitis and pneumonia among babies under one year of age and the leading cause of hospitalization among infants.
In Spain, 78% of severe cases of bronchiolitis are caused by RSV and it is estimated that almost 30% of healthy children hospitalized for RSV will require intensive care.
In the Community of Madrid, last year 92% of the cases of RSV infection that required hospital admission were under one year of age.
They study a vaccine for pregnant women that will protect the baby from the Respiratory Syncytial Virus
The maximum incidence peak was reached in epidemiological week 47 with an incidence of 400 urgent admissions/100,000 inhabitants.
2023-06-10 09:13:55
#Madrid #vaccinate #babies #bronchiolitis #October
